← FDA DRUG APPROVALS

FDA ANDA · ANDA070417

NALOXONE HYDROCHLORIDE

Sponsor: INTL MEDICATION

APPLICATION
ANDA070417
TYPE
ANDA
LATEST ACTION
1988-11-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NALOXONE HYDROCHLORIDEDiscontinued
NALOXONE HYDROCHLORIDE 0.4MG/ML · INJECTABLE · INJECTION

Approval history

1988-11-29Manufacturing (CMC) · Supplement 6AP
1988-11-29Manufacturing (CMC) · Supplement 4AP
1988-05-20Labeling · Supplement 5AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →